UCL scientists have found that people with the Alzheimer’s risk gene, APOE4, perform better in visual working memory tests than people without the gene.
People can safely receive the Covid-19 and influenza vaccine at the same time, according to a new study. The ‘Combining Influenza and Covid-19 Vaccination (ComFluCOV) study’ published as a preprint, found that immune responses to both the influenza and Covid-19 vaccine were preserved when given
A pilot service at UCLH set up by clinicians and researchers that enables ear, nose and throat (ENT) surgeons to assess hearing and ear problems remotely and shorten treatment pathways has won the ENT UK’s Best Young Consultant Led Research, Audit or Training prize.
Being a young adult aged 18 to 24 is a more important risk factor for weight gain than sex, ethnicity, geographic region, or socioeconomic area characteristics, according to a new study.
Researchers are applying AI technology to ‘unlock’ data held in patients’ health records so that it can be used to improve care, planning and research.
In a collaboration between UCLH and Imperial College, researchers have developed a new test which could help doctors more easily distinguish what kind of infection a patient may have and prescribe treatments more quickly.
Patient and public involvement (PPI) training brings about immediate and marked increases in the confidence and skills of researchers to involve the public in their work, according to a study at the BRC.
A national study involving UCLH has deepened understanding of the symptoms, signs and outcomes of patients with the novel condition vaccine-induced immune thrombocytopenia and thrombosis (VITT), associated with the Oxford/AstraZeneca vaccine.
UCLH and Cambridge University in collaboration with NHS Blood and Transplant have won government funding to apply artificial intelligence (AI) to improve blood transfusions.
UCLH is carrying out a three-month assessment of its delivery of race equality in health research as part of a project led by the National Institute of Health Research (NIHR).
A new UCLH and UCL-led observational study of patients with cerebral venous thrombosis (CVT) following COVID-19 vaccination provides a clearer guide to clinicians trying to diagnose and treat patients.
Antibodies produced by SARS-CoV-2 variants differ in their ability to neutralise other variants of the virus, according to research by UCLH and the Francis Crick Institute.
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.
